Rethinking the Customer Engagement Model in Japan for COVID-19 and Beyond L.E.K. Consulting Read more
Related Practice Life Sciences & Pharma Unlike many other markets in the world, Japan had until very recently been driven by ‘share-of-voice’, with market development and patient share being largely sensitive to sales activity. 01022024160132
Video / Webinar Life Sciences & Pharma Navigating China's Volume-Based Procurement in the Pharma Industry August 27, 2025
Article MedTech Hospital Priorities 2025 China Edition: Key Findings for Medtech and Pharma Companies June 20, 2025
Published Articles Life Sciences & Pharma The Growth of Radiotherapeutics: Addressing Supply Chain Complexity May 21, 2025
Article Life Sciences & Pharma Clinical Trial Design Strategies To Address Methodological Challenges in Psychedelics November 15, 2024